Thomas Levin Klausen

Thomas Levin Klausen

Guest Researcher


  1. Published

    First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic

    Loft, Mathias Hougaard, Christensen, C., Clausen, Malene Martini, Carlsen, Esben Andreas, Hansen, C. P., Kroman, Niels Thorndahl, Langer, Seppo W., Høgdall, Claus Kim, Madsen, J., Gillings, N., Nielsen, Carsten Haagen, Klausen, Thomas Levin, Holm, S., Loft, A., Berthelsen, A. K. & Kjær, Andreas, 2022, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63, 12, p. 1871-1879

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Positron emission tomography of the vulnerable atherosclerotic plaque in man – a contemporary review

    Pedersen, S. F., Hag, Anne Mette Fisker, Klausen, Thomas Levin, Ripa, Rasmus Sejersten, Bodholdt, R. P. & Kjær, Andreas, Nov 2014, In: Clinical Physiology and Functional Imaging. 34, 6, p. 413–425 16 p.

    Research output: Contribution to journalReviewResearchpeer-review

  3. Published

    First-in-human uPAR PET: Imaging of Cancer Aggressiveness

    Persson, M., Skovgaard, D., Brandt-Larsen, M., Christensen, C., Madsen, J., Nielsen, Carsten Haagen, Røndbjerg, T. T., Klausen, Thomas Levin, Holm, S., Loft, A., Berthelsen, A. K., Ploug, Michael, Pappot, H., Brasso, K., Kroman, Niels Thorndahl, Højgaard, Liselotte & Kjær, Andreas, 2015, In: Theranostics. 5, 12, p. 1303-16 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study

    Pfeifer, A. K., Knigge, Ulrich, Mortensen, Jann, Oturai, P., Berthelsen, A. K., Loft, A., Binderup, Tina, Rasmussen, P., Elema, D. R., Klausen, Thomas Levin, Holm, S., von Benzon, E., Højgaard, Liselotte & Kjær, Andreas, Aug 2012, In: Journal of Nuclear Medicine. 53, 8, p. 1207-15 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweight

    Svane, M. S., Johannesen, H. H., Hansen, Adam Espe, Martinussen, C., Bojsen-Møller, K. N., Hansen, M. L., Deacon, Carolyn F., Keller, S. H., Klausen, Thomas Levin, Loft, A., Kjær, Andreas, Löfgren, J., Madsbad, Sten, Holst, Jens Juul & Albrechtsen, Nicolai Jacob Wewer, 2022, In: International Journal of Obesity. 46, 11, p. 2058–2062 8 p.

    Research output: Contribution to journalLetterResearchpeer-review

Previous 1 2 Next

ID: 33555790